One-Year Clinical Outcomes Following Anterior Cruciate Ligament Reconstruction Augmented with a Reinforced Bioinductive Implant.

IF 0.8 Q4 SURGERY
Surgical technology international Pub Date : 2025-06-20
Sean Mc Millan, Jeff Murray, Elizabeth Ford
{"title":"One-Year Clinical Outcomes Following Anterior Cruciate Ligament Reconstruction Augmented with a Reinforced Bioinductive Implant.","authors":"Sean Mc Millan, Jeff Murray, Elizabeth Ford","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this study was to examine the risk of early clinical outcomes in ACL reconstructions augmented with a reinforced bio-inductive implant (RBI).</p><p><strong>Materials and methods: </strong>A retrospective chart review of a single orthopedic sports medicine surgeon was performed identifying patients who underwent primary or revision ACL reconstruction (ACLR) augmented with an RBI between January 2021 and January 2024. Inclusion criteria included: age over 14, minimum one-year follow up, and range of motion, Visual Analog Scale (VAS) and International Knee Documentation Committee (IKDC) scores at preop, three months, six months, and 12 months postoperative. Excluded patients were primary ACL repair and failure to meet the above criteria. Patients were identified for medical comorbidities and outcomes related to the need for reoperation and/or identification of graft tears.</p><p><strong>Results: </strong>Seventy-one patients met the inclusion criteria with mean follow up of 12.2 months (min. 11, max. 23, median 12). Patient demographics revealed an average age of 29 years (min. 14, max. 62, median 28). Of the 71 patients, 37 (52.1%) were male. All 71 patients had their ACLR performed arthroscopically, and 61/71 patients underwent primary ACL reconstruction (85.9%). VAS pain scores at three, six, and 12 months compared to pre-surgical scores revealed statistically significant decreases at all timepoints (Δ-3.4, Δ-3.8, Δ-3.8, respectively, p <0.001). IKDC scores at three, six, and 12 months compared to pre-surgical scores met the minimal clinically important difference (MCID) and were found to have statistically significant improvements at all timepoints (Δ25.9, Δ42.8, Δ49.7, respectively, p <0.001). Knee ROM in flexion and extension demonstrated statistically significant improvements at all timepoints post surgery compared to baseline (p <0.001). The overall rate of reoperation was 4.2% (3/71). Reasons for reoperation included one case of arthrofibrosis (1.4%), one subsequent meniscus tear (1.4%), and one graft retear (1.4%).</p><p><strong>Conclusion: </strong>The addition of an RBI to ACLR demonstrated favorable outcomes in terms of range of motion, pain, and functional outcome scores with a low rate of clinical retear at a minimum of one-year follow up.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":"45 ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical technology international","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The purpose of this study was to examine the risk of early clinical outcomes in ACL reconstructions augmented with a reinforced bio-inductive implant (RBI).

Materials and methods: A retrospective chart review of a single orthopedic sports medicine surgeon was performed identifying patients who underwent primary or revision ACL reconstruction (ACLR) augmented with an RBI between January 2021 and January 2024. Inclusion criteria included: age over 14, minimum one-year follow up, and range of motion, Visual Analog Scale (VAS) and International Knee Documentation Committee (IKDC) scores at preop, three months, six months, and 12 months postoperative. Excluded patients were primary ACL repair and failure to meet the above criteria. Patients were identified for medical comorbidities and outcomes related to the need for reoperation and/or identification of graft tears.

Results: Seventy-one patients met the inclusion criteria with mean follow up of 12.2 months (min. 11, max. 23, median 12). Patient demographics revealed an average age of 29 years (min. 14, max. 62, median 28). Of the 71 patients, 37 (52.1%) were male. All 71 patients had their ACLR performed arthroscopically, and 61/71 patients underwent primary ACL reconstruction (85.9%). VAS pain scores at three, six, and 12 months compared to pre-surgical scores revealed statistically significant decreases at all timepoints (Δ-3.4, Δ-3.8, Δ-3.8, respectively, p <0.001). IKDC scores at three, six, and 12 months compared to pre-surgical scores met the minimal clinically important difference (MCID) and were found to have statistically significant improvements at all timepoints (Δ25.9, Δ42.8, Δ49.7, respectively, p <0.001). Knee ROM in flexion and extension demonstrated statistically significant improvements at all timepoints post surgery compared to baseline (p <0.001). The overall rate of reoperation was 4.2% (3/71). Reasons for reoperation included one case of arthrofibrosis (1.4%), one subsequent meniscus tear (1.4%), and one graft retear (1.4%).

Conclusion: The addition of an RBI to ACLR demonstrated favorable outcomes in terms of range of motion, pain, and functional outcome scores with a low rate of clinical retear at a minimum of one-year follow up.

前交叉韧带重建增强生物诱导植入物后一年的临床结果。
简介:本研究的目的是检查使用增强生物诱导植入物(RBI)增强ACL重建的早期临床结果的风险。材料和方法:对一名骨科运动医学外科医生进行回顾性图表回顾,确定在2021年1月至2024年1月期间接受了经RBI增强的原发性或改进性ACL重建(ACLR)的患者。纳入标准包括:年龄超过14岁,至少随访一年,术前、术后3个月、6个月和国际膝关节文献委员会(IKDC)的运动范围、视觉模拟量表(VAS)和国际膝关节文献委员会(IKDC)评分。排除原发性ACL修复和不符合上述标准的患者。确定患者的医疗合并症和与需要再次手术和/或确定移植物撕裂相关的结果。结果:71例患者符合纳入标准,平均随访时间为12.2个月(最短11个月,最长11个月)。23,中位数12)。患者年龄平均29岁(最小14岁,最大14岁)。62,中位数28)。71例患者中,男性37例(52.1%)。所有71例患者均在关节镜下进行了ACLR, 61/71例患者进行了原发性ACL重建(85.9%)。与术前评分相比,3、6、12个月的VAS疼痛评分在所有时间点上均有统计学意义上的显著下降(分别为Δ-3.4、Δ-3.8、Δ-3.8)。结论:在ACLR中加入RBI在活动范围、疼痛和功能结果评分方面表现出良好的结果,并且在至少1年的随访中临床复发率较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
141
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信